R&D


01. Elucidating the Therapeutic Efficacy of MT101 in Enhancing Nurr1 Activity and α-synuclein Clearance
02. Identification of Proteasome-Activating Components in MT101
03. Elucidating the Efficacy of MT9801 in Nerve Regeneration and Pain Reduction
04. Elucidating the Efficacy of MT102 in AhR Activation and NLRP3 Inflammasome Inhibition
Core Infrastructure : CMC
(Chemistry Manufacturing and Controls)
